Jianbo Li

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Periprostatic venous androgen levels in a subset of patients with prostate cancer: An investigation into a novel role of testosterone in localized prostate cancer.”.

Periprostatic venous androgen levels in a subset of patients with prostate cancer: An investigation into a novel role of testosterone in localized prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.341

N/A

0DataRank · unranked

0 citations

Mohammad Alyamani, Jianbo Li, Andrei S. Purysko, Eric A. Klein, Nima Sharifi +1 more

The effect of deep AR suppression with enzalutamide or apalutamide on endogenous glucocorticoids: Implications for adverse effects and development of combination therapies.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.17

N/A

0DataRank · unranked

0 citations

Mohammad Alyamani, Jianbo Li, Mona Patel, Michael Berk, Susan Taylor +8 more

Gut Microbiome–Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0766

N/A

0DataRank · unranked

76 citations

Bryan D. Naelitz, Zeneng Wang, Xun Jia, Jianbo Li, Meir J. Stampfer +4 more

Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage

Histopathology(2024)10.1111/his.15231

N/A

0DataRank · unranked

30 citations

Lara R. Harik, Eric A. Klein, Jianbo Li, Dillon Corrigan, Shiguang Liu +18 more